1Y Annualised Return
▲2.62%
3Y Annualised Return
▼-0.77%
5Y Annualised Return
▲37.06%
Fredun Pharmaceuticals Stock Performance
|
|
|
Fredun Pharmaceuticals Company background
Founded in: 1987
Managing director: Fredun N Medhora
Incorporated in 1987 as a private limited company, Fredun Pharmaceuticals (FPL) was converted into a public limited company in Mar.94. The Company was promoted by Nariman Medhora and Daulat N Medhora. The promoters initially established D N Pharma, a proprietary firm, for the manufacture and export of pharmaceutical formulations. Since 1993, D N Pharmas operations were phased out in order to switch over the business to FPL. The Company is well diversified in the business ranging from Formulations to Diagnostics to Consultancy. The Company has an unique range of products, from niche formulations , antidiabetics to the latest antiretroviral and anti Hypertensive products. It supplies finished formulations to over 42 Countries globally. It is associated with many Governments of different countries which have also realised the need for robust and consistent healthcare systems.The Company was set up with the objective of providing facilities for manufacturing and marketing of various pharmaceutical formulations like tablets, capsules, drysyrups and ointments. It then set up a formulation unit at Palghar (Thane District), Maharashtra, which commenced commercial production in Aug.94. FPL had been carrying out manufacturing operations on loan licence for reputed pharmaceutical companies like Cipla. It also manufactured for some merchant exporters, including Merind.In Apr.96, the company came out with a public issue to register its products in the overseas market for exports to partfinance the expansion of its business activities and to repay one of the term loans and unsecured loans to reduce the interest burden. Company is very much optimistic of revival of companys turnover by having excellent export order in hand. Company also in process of registering various drugs with different countires such as Nepal, Tanzaniya, Uganda Sri Lanka.In 2013, Company launched 36 new products and filed 60 new products for registration. It launched a herbal dietary supplement in Africa. During 2015, three new granulation departments were introduced to the existing two departments. It launched 19 new products under the Cosmeceuticals OEM Division in 2023. It introduced 14 new products in the pet pharmaceuticals line, with another 36 in the works. It launched 16 products into the Pet Treat and Nutritional Supplement category.
As of 11 Jul, 2025, Fredun Pharmaceuticals share price is ₹860.2. The stock opened at ₹848 and had closed at ₹844.2 the previous day. During today’s trading session, Fredun Pharmaceuticals share price moved between ₹848.00 and ₹864.25, with an average price for the day of ₹856.13. Over the last 52 weeks, the stock has recorded a low of ₹635.00 and a high of ₹904.00. In terms of performance, Fredun Pharmaceuticals share price has increased by 22.6% over the past six months and has increased by 2.62% over the last year.
Fredun Pharmaceuticals SIP Return Calculator
Over the past
1 year
3 years
5 years
Total Investment of ₹65,00,000
Would have become ₹65,86,225 (+1.33%)
Daily SIP of ₹25,000 would have become ₹65,86,225 in 1 year with a gain of ₹86,225 (+1.33%)
Fredun Pharmaceuticals Fundamental
Market Cap (in crs)
406.16
Face Value
10
Turnover (in lacs)
149.97
Key Metrics
Qtr Change %
Near 52W High of ₹904.00
31.6
Dividend yield 1yr %
Low in industry
0.1
Fredun Pharmaceuticals Technical Analysis
Moving Averages Analysis
Moving Averages Analysis
861.5
Current Price
5Day EMA
839.60
10Day EMA
829.30
12Day EMA
826.30
20Day EMA
814.60
26Day EMA
805.80
50Day EMA
777.50
100Day EMA
750.80
200Day EMA
749.10
5Day SMA
834.80
10Day SMA
824.90
20Day SMA
822.30
30Day SMA
795.70
50Day SMA
765.10
100Day SMA
725.00
150Day SMA
722.40
200Day SMA
726.90
Delivery & Volume
| Period | Combined Delivery Volume | NSE+BSE Traded Volume |
|---|---|---|
Day Rs | 11531 Rs | 17434 Rs |
Week Rs | 8734 Rs | 17415 Rs |
Month Rs | 7272 Rs | 16327 Rs |
Resistance & Support
857.48
Pivot
Resistance
First Resistance
866.97
Second Resistance
873.73
Third Resistance
883.22
Support
First Support
850.72
Second support
841.23
Third Support
834.47
Relative Strength Index
68.65
Money Flow Index
69.23
MACD
20.53
MACD Signal
20.09
Average True Range
29.40
Average Directional Index
23.05
Rate of Change (21)
7.61
Rate of Change (125)
22.19
Fredun Pharmaceuticals Peer comparison
| Index Name | Market Price | Market Cap | 52W Low | 52W High | Prev. Close | 1W Return | 1M Return | 6M Return | 1Y Return | 3Y Return | Dividend Yield | PE Ratio | Industry PE | PB Ratio |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
110.75 | 393.16 | 96.8 | 176.59 | 110.60 | -3.22% | -6.31% | -26.46% | -0.69% | -7.04% | 0.00% | 47.86 | 42.82 | 2.92 | |
19.89 | 445.83 | 15.51 | 56.5 | 19.46 | -12.38% | -18.12% | -48.03% | -33.64% | -17.34% | 0.00% | 0.00 | 42.82 | 0.47 | |
112.10 | 417.73 | 30 | 133.5 | 110.10 | -3.38% | -9.34% | 34.18% | 268.76% | 324.62% | 0.00% | 0.00 | 42.82 | -16.29 | |
61.62 | 373.57 | 51 | 107.79 | 62.45 | -4.94% | -3.16% | -6.16% | -4.16% | 17.37% | 0.00% | 82.72 | 42.82 | 3.89 | |
Infinium Pharmachem Ltd. | 277.00 | 277.00 | - | - | - | - | - | - | - | - | - | - | - | - |
Influx Healthtech Ltd. | 179.05 | 179.05 | - | - | - | - | - | - | - | - | - | - | - | - |
Fredun Pharmaceuticals Share Price FAQs
How to buy Fredun Pharmaceuticals shares?
You can easily buy Fredun Pharmaceuticals shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.
What is the 52-week high and low of Fredun Pharmaceuticals ?
The 52-week high and low of Fredun Pharmaceuticals share price is ₹904 and ₹635 as of 11/7/2025.
Please be aware that Fredun Pharmaceuticals stock prices are subject to continuous fluctuations due to various factors.
Open Demat Account